Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Solid Biosciences Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
SLDB
Nasdaq
8731
https://www.solidbio.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Solid Biosciences Inc
How Sleeper Biotech Solid Biosciences, With A 687% Gain, Is Making A Comeback
- Mar 28th, 2024 3:31 pm
Solid Biosciences to Participate at Cantor’s Virtual Muscular Dystrophy Symposium
- Mar 27th, 2024 11:00 am
Solid Biosciences Provides Fourth Quarter and Full-Year 2023 Business Update and Financial Results
- Mar 13th, 2024 11:44 am
Solid Biosciences Announces Licensing Agreement with Armatus Bio for the Use of AAV-SLB101, a Proprietary, Muscle-Targeted Capsid, in the Development of an RNAi Therapy to treat FSHD
- Mar 7th, 2024 12:00 pm
Solid Biosciences to Participate at Upcoming Investor Conferences
- Mar 6th, 2024 1:00 pm
14 Stocks With Heavy Insider Buying In 2024
- Feb 29th, 2024 8:02 am
Biotech Stock Roundup: VRTX/CRSP Gene Therapy Label Expansion, ALLK Falls on Update
- Jan 18th, 2024 3:21 pm
Solid Biosciences' (SLDB) DMD Drug Gets Orphan Tag, Stock Up
- Jan 17th, 2024 4:27 pm
Solid Biosciences Granted FDA Orphan Drug Designation for Duchenne Muscular Dystrophy Gene Therapy Candidate SGT-003
- Jan 16th, 2024 1:00 pm
Solid Biosciences (SLDB) Rises 271% in 3 Months: Here's Why
- Jan 15th, 2024 3:18 pm
Solid Biosciences Announces $109 Million Private Placement
- Jan 8th, 2024 12:09 pm
Solid Biosciences to Participate at 42nd Annual J.P. Morgan Healthcare Conference
- Jan 4th, 2024 1:00 pm
While institutions invested in Solid Biosciences Inc. (NASDAQ:SLDB) benefited from last week's 68% gain, private equity firms stood to gain the most
- Dec 9th, 2023 2:16 pm
Solid Biosciences' (SLDB) DMD Drug Gets Fast Track Tag, Stock Up
- Dec 8th, 2023 10:37 am
Solid Biosciences Receives FDA Fast Track Designation for Duchenne Muscular Dystrophy Gene Therapy SGT-003
- Dec 7th, 2023 1:00 pm
Solid Biosciences to Participate at 35th Annual Piper Sandler Healthcare Conference
- Nov 22nd, 2023 1:00 pm
The Zacks Analyst Blog Highlights Arcellx, Bristol Myers Squibb, Solid Biosciences, Vertex Pharmaceuticals and CRISPR Therapeutics
- Nov 17th, 2023 11:00 am
Biotech Stock Roundup: BMY's Drug Approval, VRTX & CRSP Gene Therapy Get MHRA Nod
- Nov 16th, 2023 3:30 pm
Solid Biosciences (SLDB) Stock Up as FDA Clears DMD Drug IND
- Nov 16th, 2023 1:29 pm
Solid Biosciences Announces IND Clearance by FDA for Duchenne Muscular Dystrophy Gene Therapy Candidate SGT-003
- Nov 14th, 2023 9:05 pm
Scroll